1-(6-anilino-2-methylpyrimidin-4-yl)-3-N-(4-morpholin-4-ylphenyl)-1,2,4-triazole-3,5-diamine;1-(6-anilinopyrimidin-4-yl)-3-N-(4-morpholin-4-ylphenyl)-1,2,4-triazole-3,5-diamine;3-N-(3,5-dimethoxyphenyl)-1-(1,3-thiazol-2-yl)-1,2,4-triazole-3,5-diamine;5-N-(3,5-dimethoxyphenyl)-1-(1,3-thiazol-2-yl)-1,2,4-triazole-3,5-diamine
C71H76N30O6S2 — CID 157059347
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-(6-anilino-2-methylpyrimidin-4-yl)-3-N-(4-morpholin-4-ylphenyl)-1,2,4-triazole-3,5-diamine;1-(6-anilinopyrimidin-4-yl)-3-N-(4-morpholin-4-ylphenyl)-1,2,4-triazole-3,5-diamine;3-N-(3,5-dimethoxyphenyl)-1-(1,3-thiazol-2-yl)-1,2,4-triazole-3,5-diamine;5-N-(3,5-dimethoxyphenyl)-1-(1,3-thiazol-2-yl)-1,2,4-triazole-3,5-diamine
1-(6-anilino-2-methylpyrimidin-4-yl)-3-N-(4-morpholin-4-ylphenyl)-1,2,4-triazole-3,5-diamine;1-(6-anilinopyrimidin-4-yl)-3-N-(4-morpholin-4-ylphenyl)-1,2,4-triazole-3,5-diamine;3-N-(3,5-dimethoxyphenyl)-1-(1,3-thiazol-2-yl)-1,2,4-triazole-3,5-diamine;5-N-(3,5-dimethoxyphenyl)-1-(1,3-thiazol-2-yl)-1,2,4-triazole-3,5-diamine (PubChem CID 157059347) has the molecular formula C71H76N30O6S2 and a molecular weight of 1509.73 g/mol. Its IUPAC name is 1-(6-anilino-2-methylpyrimidin-4-yl)-3-N-(4-morpholin-4-ylphenyl)-1,2,4-triazole-3,5-diamine;1-(6-anilinopyrimidin-4-yl)-3-N-(4-morpholin-4-ylphenyl)-1,2,4-triazole-3,5-diamine;3-N-(3,5-dimethoxyphenyl)-1-(1,3-thiazol-2-yl)-1,2,4-triazole-3,5-diamine;5-N-(3,5-dimethoxyphenyl)-1-(1,3-thiazol-2-yl)-1,2,4-triazole-3,5-diamine.
Molecular Properties
| Compound Name | 1-(6-anilino-2-methylpyrimidin-4-yl)-3-N-(4-morpholin-4-ylphenyl)-1,2,4-triazole-3,5-diamine;1-(6-anilinopyrimidin-4-yl)-3-N-(4-morpholin-4-ylphenyl)-1,2,4-triazole-3,5-diamine;3-N-(3,5-dimethoxyphenyl)-1-(1,3-thiazol-2-yl)-1,2,4-triazole-3,5-diamine;5-N-(3,5-dimethoxyphenyl)-1-(1,3-thiazol-2-yl)-1,2,4-triazole-3,5-diamine |
|---|---|
| PubChem CID | 157059347 |
| Molecular Formula | C71H76N30O6S2 |
| Molecular Weight | 1509.73 g/mol |
| Exact Mass | 1508.60 |
| IUPAC Name | 1-(6-anilino-2-methylpyrimidin-4-yl)-3-N-(4-morpholin-4-ylphenyl)-1,2,4-triazole-3,5-diamine;1-(6-anilinopyrimidin-4-yl)-3-N-(4-morpholin-4-ylphenyl)-1,2,4-triazole-3,5-diamine;3-N-(3,5-dimethoxyphenyl)-1-(1,3-thiazol-2-yl)-1,2,4-triazole-3,5-diamine;5-N-(3,5-dimethoxyphenyl)-1-(1,3-thiazol-2-yl)-1,2,4-triazole-3,5-diamine |
| SMILES | COc1cc(Nc2nc(N)n(-c3nccs3)n2)cc(OC)c1.COc1cc(Nc2nc(N)nn2-c2nccs2)cc(OC)c1.Cc1nc(Nc2ccccc2)cc(-n2nc(Nc3ccc(N4CCOCC4)cc3)nc2N)n1.Nc1nc(Nc2ccc(N3CCOCC3)cc2)nn1-c1cc(Nc2ccccc2)ncn1 |
| InChI | InChI=1S/C23H25N9O.C22H23N9O.2C13H14N6O2S/c1-16-25-20(27-17-5-3-2-4-6-17)15-21(26-16)32-22(24)29-23(30-32)28-18-7-9-19(10-8-18)31-11-13-33-14-12-31;23-21-28-22(27-17-6-8-18(9-7-17)30-10-12-32-13-11-30)29-31(21)20-14-19(24-15-25-20)26-16-4-2-1-3-5-16;1-20-9-5-8(6-10(7-9)21-2)16-12-17-11(14)19(18-12)13-15-3-4-22-13;1-20-9-5-8(6-10(7-9)21-2)16-12-17-11(14)18-19(12)13-15-3-4-22-13/h2-10,15H,11-14H2,1H3,(H,25,26,27)(H3,24,28,29,30);1-9,14-15H,10-13H2,(H,24,25,26)(H3,23,27,28,29);2*3-7H,1-2H3,(H3,14,16,17,18) |
| InChIKey | ABDHHDSWDFKLSE-UHFFFAOYSA-N |
| XLogP | 10.37 |
| TPSA | 438.30 Ų |
| H-Bond Donors | 10 |
| H-Bond Acceptors | 38 |
| Rotatable Bonds | 22 |
| Heavy Atoms | 109 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1509.73 |
| LogP ≤ 5 | 10.37 |
| H-Bond Donors ≤ 5 | 10 |
| H-Bond Acceptors ≤ 10 | 38 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'anil_di_alk_A(478)', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 157059347 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.